Scott Epstein

Avoro Capital Advisors Llc

Assets Managed

$10.165B

Holdings

Last Quarter

2026 - Q1

Filed Date

22d ago

Growth Rate

-0.09%(2Q avg: 15.71%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avoro Capital Advisors Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 30 positions.

Assets under management

The assets under management (AUM) of Avoro Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 10.165B in assets, with a quarterly growth rate of -0.09% and a 2-quarter average growth rate of 15.71%. The portfolio is managed by Scott Epstein, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
UTHR United Therapeutics Corp Recent Activity Increased 15.51%	15.45%	$1.57B 3.01M shares@ $521.54 avg price	Increased 15.51%
ASND Ascendis Pharma A S - Adr Recent Activity Decreased -1.91%	11.4%	$1.158B 5.062M shares@ $228.73 avg price	Decreased -1.91%
MDGL Madrigal Pharmaceuticals Inc Recent Activity Increased 0.6%	9.37%	$951.763M 1.818M shares@ $523.47 avg price	Increased 0.6%
KRYS Krystal Biotech Inc Recent Activity	7.35%	$746.258M 2.889M shares@ $258.32 avg price
ARGX Argenx Se - Adr Recent Activity Increased 1.02%	7.19%	$730.25M 1M shares@ $730.25 avg price	Increased 1.02%
ARWR Arrowhead Pharmaceuticals In Recent Activity Increased 0.71%	6.61%	$670.89M 10.7M shares@ $62.7 avg price	Increased 0.71%
KYMR Kymera Therapeutics Inc Recent Activity	6.13%	$622.572M 7.475M shares@ $83.3 avg price
APLS Apellis Pharmaceuticals Inc Recent Activity	4.84%	$491.7M 12.222M shares@ $40.23 avg price
CNTA Centessa Pharmaceuticals-adr Recent Activity Decreased -21.47%	4.47%	$454.018M 11.43M shares@ $39.73 avg price	Decreased -21.47%
CELC Celcuity Inc Recent Activity Increased 14.92%	3.82%	$388.273M↑ Call 3.575M shares@ $108.61 avg price	Increased 14.92%

1-10 of 30